Fulton Bank’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,178
Closed -$228K 617
2023
Q4
$228K Buy
+10,178
New +$210K 0.01% 543
2023
Q3
Sell
-8,606
Closed -$220K 570
2023
Q2
$220K Buy
8,606
+76
+0.9% +$2K 0.01% 514
2023
Q1
$254K Buy
8,530
+536
+7% +$15.6K 0.01% 476
2022
Q4
$216K Buy
+7,994
New +$195K 0.01% 486

Other funds holding AVNS

Fulton Bank's AVNS Position: Q1 2024 in Review

Fulton Bank sold out of Avanos Medical (AVNS) in Q1 2024, closing a stake of 10,178 shares — an estimated $228K sold.

Fulton Bank first reported a position in AVNS in Q4 2022 and held it in 4 quarters. The position peaked at $254K in Q1 2023. 261 funds tracked by Wall St. Rank hold AVNS as of Q1 2024.

  • Fulton Bank reported no remaining Avanos Medical position as of Q1 2024 after selling out during the quarter.
  • Fulton Bank sold 10,178 Avanos Medical shares in Q1 2024, an estimated $228K.
  • Fulton Bank first reported a position in Avanos Medical in Q4 2022 and held it in 4 quarters.
  • Fulton Bank's Avanos Medical position peaked at $254K in Q1 2023.
  • 261 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2024.

Based on Fulton Bank's 13F filing for Q1 2024, filed 10 Apr 2024.